Bazoukis George, Hui Jeremy Man Ho, Lee Yan Hiu Athena, Chou Oscar Hou In, Sfairopoulos Dimitrios, Vlachos Konstantinos, Saplaouras Athanasios, Letsas Konstantinos P, Efremidis Michael, Tse Gary, Vassiliou Vassilios S, Korantzopoulos Panagiotis
Department of Cardiology, Larnaca General Hospital, Inomenon Polition Amerikis, Larnaca, Cyprus.
Department of Basic and Clinical Sciences, University of Nicosia Medical School, 2414, Nicosia, Cyprus.
Heart Fail Rev. 2022 Nov;27(6):2095-2118. doi: 10.1007/s10741-022-10263-5. Epub 2022 Aug 31.
Despite the strict indications for cardiac resynchronization therapy (CRT) implantation, a significant proportion of patients will fail to adequately respond to the treatment. This systematic review aims to present the existing evidence about the role of cardiac magnetic resonance (CMR) in identifying patients who are likely to respond better to the CRT. A systematic search in the MedLine database and Cochrane Library from their inception to August 2021 was performed, without any limitations, by two independent investigators. We considered eligible observational studies or randomized clinical trials (RCTs) that enrolled patients > 18 years old with heart failure (HF) of ischaemic or non-ischaemic aetiology and provided data about the association of baseline CMR variables with clinical or echocardiographic response to CRT for at least 3 months. This systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA Statement). Following our search strategy, 47 studies were finally included in our review. CMR appears to have an additive role in identifying the subgroup of patients who will respond better to CRT. Specifically, the presence and the extent of myocardial scar were associated with increased non-response rates, while those with no scar respond better. Furthermore, existing data show that scar location can be associated with CRT response rates. CMR-derived markers of mechanical desynchrony can also be used as predictors of CRT response. CMR data can be used to optimize the position of the left ventricular lead during the CRT implantation procedure. Specifically, positioning the left ventricular lead in a branch of the coronary sinus that feeds an area with transmural scar was associated with poorer response to CRT. CMR can be used as a non-invasive optimization tool to identify patients who are more likely to achieve better clinical and echocardiographic response following CRT implantation.
尽管心脏再同步治疗(CRT)植入有严格的适应症,但仍有相当一部分患者对该治疗反应不佳。本系统评价旨在阐述心脏磁共振成像(CMR)在识别可能对CRT反应更好的患者中所起作用的现有证据。两名独立研究人员对MedLine数据库和Cochrane图书馆自创建至2021年8月进行了全面检索,无任何限制。我们纳入了符合条件的观察性研究或随机临床试验(RCT),这些研究纳入了年龄大于18岁、患有缺血性或非缺血性病因心力衰竭(HF)的患者,并提供了基线CMR变量与CRT临床或超声心动图反应至少3个月相关性的数据。本系统评价按照系统评价和Meta分析的首选报告项目(PRISMA声明)进行。按照我们的检索策略,最终47项研究纳入了本评价。CMR在识别对CRT反应更好的患者亚组方面似乎具有辅助作用。具体而言,心肌瘢痕的存在和范围与无反应率增加相关,而无瘢痕者反应更好。此外,现有数据表明瘢痕位置可能与CRT反应率相关。CMR衍生的机械不同步标志物也可作为CRT反应的预测指标。CMR数据可用于在CRT植入过程中优化左心室导线的位置。具体而言,将左心室导线置于为透壁瘢痕区域供血的冠状静脉窦分支中与CRT反应较差相关。CMR可作为一种非侵入性优化工具,用于识别CRT植入后更有可能获得更好临床和超声心动图反应的患者。